Orbital inflammation caused by bisphosphonates case report and literature review.

GONZALEZ-BARLATAY, JOAQUÍN MIGUEL; ORTIZ-BASSO, TOMÁS; HERNÁNDEZ GAUNA, GUILLERMO; VIGO, RODOLFO LUIS; PRÉMOLI, EDUARDO JORGE

International Journal of Ocular Oncology and Oculoplasty

Khyati Education and Research Foundation

Año: 2019 vol. 2 p. 148 - 151

2581-5024

Bisphosphonates are drugs broadly disseminated and frequently used in clinical practice. Ocular adverse effects are already known and orbital inflammation outstands as one of the most severe. It is clinically evident by palpebral edema, conjunctival congestion, chemosis, ocular motility impairment, pain, diplopia, and blurred vision. It can affect both eyes and be accompanied by anterior uveitis. Timely treatment is vital to expect a favorable outcome. Systemic corticosteroids are the treatment of choice. We present the case of a patient whose inflammation improved after treatment with oral doses of diclofenac